L01EK01 Axitinib
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 2 drugs in this drug class.
- 2 prescription (Rx)
Active ingredient: Axitinib – all drugs with this active ingredient, also in combination.
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
- L01EK01 Axitinib 2 drugs
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Inlyta (Pfizer Canada, 1 mg, 5 mg) | prescription (Rx) |
| Inlyta (Pfizer Canada, 3 mg, 7 mg) PM | prescription (Rx) |
Other classes of the same level
- L01EK04 Fruquintinib 1 drug
Other names of the drug class
- English (United Kingdom): L01EK01 axitinib
- German: L01EK01 Axitinib
- German (Austria): L01EK01 Axitinib
- Italian: L01EK01 AXITINIB
- Turkish: L01EK01 aksitinib
- Spanish: L01EK01 Axitinib
- German (Switzerland): L01EK01 Axitinib
- French (Switzerland): L01EK01 Axitinib
- Italian (Switzerland): L01EK01 Axitinib
- Dutch: L01EK01 Axitinib
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EK01
Ask your doctor or pharmacist for advice.
